Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
4.25 +0.23 / +5.72%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.16 -0.09 / -2.12%
Volume: 12.7K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues5.0M0.007.0M10.8M
Cost of Goods Sold0.000.00--495.0K
Depreciation And Amortization47.0K35.0K54.0K306.0K
Operating ExpensesGross Income5.0M-35.0K--10.0M
General Expenses33.7M27.0M53.0M121.3M
Research And Development27.0M20.0M33.7M51.4M
Total Operating Expenses33.7M27.1M53.1M122.1M
Non-Operating ExpensesOperating Income-28.7M-27.1M-46.1M-111.2M
Extraordinary Charge0.000.00-1.0M0.00
Other Expenses221.0K1.7M161.0K121.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.4M-25.4M-46.7M-110.8M
Income Taxes0.000.000.00-700.0K
Discontinued Operations246.0K0.000.000.00
Extraordinary Items0.002.6M0.000.00
Net Income-28.1M-25.4M-46.7M-111.5M
Shares To Calculate EPSShares To Calculate EPS67.4M71.6M81.0M91.0M
Shares To Calculate EPS Diluted67.4M71.6M81.0M91.0M
Earnings Per ShareEPS-$0.42-$0.32-$0.58-$1.23
EPS Diluted-$0.42-$0.35-$0.58-$1.23